跳至主要内容
临床试验/EUCTR2019-000801-61-BE
EUCTR2019-000801-61-BE进行中(未招募)1 期

Toward an optimal accelerated Tick-Borne Encephalitis (TBE) vaccination schedule for the last-minute traveler - FASTBEPROTECT

Institute of Tropical Medicine Antwerp0 个研究点目标入组 75 人开始时间: 2019年4月8日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
75

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1. =18 to =60 years of age at time of inclusion
  • 2. Willingness to provide written informed consent
  • 3. Personnel members at the Belgian Defense
  • 4. Prepared to follow the study schedule
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 75
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1. Seropositive for TBE (tested during screening visit).
  • 2. Subjects with a known allergy to one of the components of the vaccine
  • 3. Immune depressed subjects or subjects who take immunodepressant and/or –stimulant medication
  • 4. Planned land deployment to TBE endemic regions during the study period
  • 5. Ongoing pregnancy or active child wish (for female subjects)
  • 6. Planned vaccination with an inactivated vaccine within 2 weeks before or after each vaccination or with a live attenuated vaccines within 1 month before or after each vaccination
  • 7. Yellow fever vaccination planned within the whole study period

研究者

发起方
Institute of Tropical Medicine Antwerp

相似试验